News from us and our partners

Tags

Topics

0 results

News
28 May, 2024
Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector
News
28 May, 2024
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
News
28 May, 2024
NodThera announces appointment of Daniel Swisher as Chief Executive Officer
News
22 May, 2024
Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause
News
21 May, 2024
Inspirna announces appointment of Karim Benhadji, M.D., as Chief Medical Officer and retirement of Robert Wasserman, M.D.
News
21 May, 2024
Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors
News
16 May, 2024
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
News
14 May, 2024
Redx confirms changes to Board composition
News
13 May, 2024
Inventiva's NATIVE trial data published in Nature Communications
News
13 May, 2024
May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy
News
7 May, 2024
GenSight Biologics raises over €9.2M in share offering
News
6 May, 2024
Mediar advances first-in-class fibrosis portfolio to the clinic with first cohort dosing in Phase 1 trial of MTX-463 and establishes clinical advisory board
News
6 May, 2024
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
News
2 May, 2024
Amolyt Pharma granted FDA Fast Track Designation for eneboparatide for the treatment of hypoparathyroidism
News
2 May, 2024
Biotalys starts field trials for second Biofungicide
News
30 April, 2024
Biotalys appoints Laura J. Meyer to Board of Directors

Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

NodThera announces appointment of Daniel Swisher as Chief Executive Officer

Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause

Inspirna announces appointment of Karim Benhadji, M.D., as Chief Medical Officer and retirement of Robert Wasserman, M.D.

Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH

Redx confirms changes to Board composition

Inventiva's NATIVE trial data published in Nature Communications

May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy

GenSight Biologics raises over €9.2M in share offering

Mediar advances first-in-class fibrosis portfolio to the clinic with first cohort dosing in Phase 1 trial of MTX-463 and establishes clinical advisory board

Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Amolyt Pharma granted FDA Fast Track Designation for eneboparatide for the treatment of hypoparathyroidism

Biotalys starts field trials for second Biofungicide

Biotalys appoints Laura J. Meyer to Board of Directors